Daily Intelligence Brief
Hair Relaxer and Uber Lead a Concentrated Filing Day
Chemical-straightener and passenger-assault claims set the pace in a concentrated 86-filing day, with Hair Relaxer (3060) and Uber Passenger Sexual Assault (3084) each adding 15 complaints. Douglas & London filed nine Hair Relaxer matters, followed by Keller Postman LLC with two, while Cutter Law PC supplied 12 of Uber’s filings and Reich & Binstock LLP added one. Talcum Powder (2738) followed with 13 complaints, 12 from The Miller Firm LLC and one from Wagstaff Law Firm, underscoring continued firm concentration in the high-volume consumer-product docket. Zantac (2924) added seven Keller Postman LLC filings, while Depo-Provera (3140) logged six complaints divided between Heninger Garrison Davis and Schlichter Bogard LLP, with two each. See the full filing feed and firm-level breakdowns here.
Suboxone MDL Sets Provider-Deposition Procedures
On July 16, 2026, Suboxone (3092) issued Case Management Order No. 23 governing scheduling of healthcare-provider depositions for Core Discovery Plaintiffs. The order establishes procedures for that discovery phase; it does not resolve general causation, product claims, or liability. For counsel, the concrete development is a new framework for organizing provider testimony and coordinating deposition-related discovery in the MDL.
Systematic Review Finds Digital-Communication Effects Depend on Context
A July 20, 2026 Journal of Adolescence systematic review synthesized 10 U.S. studies on parent-adolescent digital communication and relationship quality. The review found inconsistent associations, partly because studies measured different communication purposes and relied heavily on frequency-based measures; it concluded that digital communication generally supplements rather than replaces in-person interaction. The study is contextual research, not evidence that any specific platform caused an individual injury, but it flags measurement and purpose as important issues for expert analysis in youth social-media litigation.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
